JAPANESE CIRCULATION JOURNAL
Online ISSN : 1347-4839
Print ISSN : 0047-1828
ISSN-L : 0047-1828
60 巻, 3 号
選択された号の論文の10件中1~10を表示しています
Special Article
Clinical Study
  • Hideki Hashimoto, Tsutomu Tamura, Yuji Ikari, Kazuhiro Hara, Fumihiko ...
    原稿種別: None
    専門分野: None
    1996 年 60 巻 3 号 p. 142-148
    発行日: 1996年
    公開日: 2002/01/25
    ジャーナル フリー
    The outcome of aortic balloon valvuloplasty (ABV) was compared with that of aortic valve replacement (AVR) in aortic stenosis (AS) patients more than 60 years old. The indications for ABV included low respiratory and renal function, cancer, the patient's refusal of surgery, and low daily activity. Twenty six patients underwent AVR and 13 underwent ABV. Initially, the AVR group was younger and more symptomatic than the ABV group. Two perioperative deaths occurred in the AVR group, while there were none in the ABV group. Twenty-four AVR patients and 12 ABV patients had a successful outcome, with remarkable pressure gradient reduction in both groups. In the follow-up, only 1 death and no cardiac events were detected in the AVR group (mean follow-up of 27 months), whereas 3 deaths, 6 heart failures, 2 repeated ABV, and 4 AVR were seen in the ABV group (mean follow-up of 10 months). The data showed that ABV was safer than AVR, but a higher rate of restenosis limited its efficacy. In the ABV group, a higher ratio of balloon size to aortic diameter correlated with longer event-free survival. We concluded that for elderly AS patients, ABV should be used only in those with high surgical risk as a palliative therapy or a bridge therapy to AVR, and AVR should be primarily recommended under rigid evaluation of the patient's physical status. (Jpn Circ J 1996; 60: 142 - 148)
  • Special Reference to TAT/PIC and FPA/PIC
    Hitoshi Uenomachi, Masahiro Sonoda, Taiki Miyauchi, Narihito Harubyu, ...
    原稿種別: None
    専門分野: None
    1996 年 60 巻 3 号 p. 149-156
    発行日: 1996年
    公開日: 2002/01/25
    ジャーナル フリー
    To clarify the relationship between the results of intracoronary thrombolytic therapy (ICT) and fibrino-coagulation in patients with acute myocardial infarction (AMI), the thrombin-antithrombin III complex (TAT) and fibrinopeptide A (FPA), as indices of accelerated coagulation, and the plasmin- α 2-plasmin inhibitor complex (PIC), as an index of accelerated fibrinolysis in peripheral blood, were measured just before and after heparin injection (5,000 U), and immediately after ICT. Twenty-four patients with AMI were divided into 2 groups according to the results of ICT; successful ICT (group S) and unsuccessful ICT (group F). As a control group (group C), 14 age-matched normal volunteers were also studied. The levels of TAT and FPA before ICT were significantly higher in groups S and F than in group C (p<0.01). The TAT level before ICT in group F was higher than that in group S (p=0.07), however, the TAT, FPA and PIC levels showed no significant differences between groups S and F at each sampling time. TAT/PIC before ICT was significantly higher in group F than in group S (F: 0.026±0.020 vs S: 0.008±0.004, p<0.05), whereas there was no remarkable difference in FPA/PIC between groups S and F. These results indicate that hyper-coagulation had occurred in the AMI cases and that coagulation had been more accelerated in group F. TAT/PIC might be an index of the equilibrium of the fibrino-coagulating system. Therefore, TAT/PIC measurement before thrombolytic therapy may be more useful than TAT measurement alone for evaluating recanalization in ICT. (Jpn Circ J 1996; 60: 149 - 156)
Experimental Study
  • Shuji Ishida, Morio Ito, Naohiko Takahashi, Takao Fujino, Tadafumi Aki ...
    原稿種別: None
    専門分野: None
    1996 年 60 巻 3 号 p. 157-165
    発行日: 1996年
    公開日: 2002/01/25
    ジャーナル フリー
    Caffeine induces delayed afterdepolarizations (DADs) and triggered activity in isolated cardiac tissue. We investigated the ability of caffeine to induce triggered ventricular arrhythmias in rabbits in vivo. During continuous infusion of caffeine at doses of 0.3 or 1.0 mg/kg per min, ventricular pacing was performed with 50 stimuli with a cycle length of 220 msec (basic pacing train) every 5 min until ventricular tachycardia (VT) was induced. The effects of programmed stimulation and pharmacologic agents on the induction of ventricular ectopic beats (VEBs) were examined. Pacing protocols were carried out in the presence of vagal-induced slowing of sinus rhythm. VT was induced by a basic pacing train during the infusion of caffeine at 1.0 mg/kg per min, but not at 0.3 mg/kg per min. An increase in the pacing rate or the number of stimuli resulted in 1) a decrease in the first postpacing interval, and 2) an increase in the number of postpacing VEBs. Induction of VT was suppressed by intravenous bolus injections of verapamil, propranolol and adenosine. At the time of the initial induction of VT, the plasma concentration of caffeine was 87±2 μg/ml and the plasma level of norepinephrine increased from 666±166 pg/ml at baseline to 1121±245 pg/ml. These results suggest that catecholamine-associated triggered activity may be responsible for caffeine-induced VT. (Jpn Circ J 1996; 60: 157 - 165)
Case Report
feedback
Top